Eye scan for hydroxychloroquine users
Part of Cancer clinical trials.
This study uses a special eye scan to check the health of the retina at the back of the eye in people who have been taking hydroxychloroquine (a medicine for autoimmune conditions) for at least a year. The goal is to see if the drug causes any early changes in the eye's blood vessels, so that problems can be caught early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old.
- Have taken hydroxychloroquine for one year or more.
- Your disease that requires hydroxychloroquine should be stable and managed by a doctor.
- No serious eye conditions (like diabetic retinopathy, age-related macular degeneration, or high myopia).
- No prior eye surgery or eye injury.
- No uncontrolled high blood pressure or other vascular diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of eye test (ERG) to detect early damage from hydroxychloroquine, a drug used for conditions like lupus and rheumatoid arthritis. If you take hydroxychloroquine or have never taken it, you might help find better ways to protect your vision.
This study uses a special, high-detail eye imaging machine to take clear pictures of the outer retina. It may help researchers understand these eye conditions better, and how the eye images look when people have an outer retinal disease.
This study looks at how Plaquenil (hydroxychloroquine) can harm the retina (the eye’s light-sensing layer) and whether genetics affect who gets affected. You may help by sharing medical details and providing an eye-related blood sample so researchers can compare gene patterns to eye findings.
This study looks at whether it is safe for people aged 55 and older with long-standing, stable lupus to stop taking hydroxychloroquine (a medicine that helps control lupus) without their disease flaring up. If you have been taking this medicine for at least 7 years and your lupus has been quiet for a while, you may be able to join.
This study uses a special eye scan to take detailed pictures of the back of the eye in people with various retinal conditions. It may help doctors better understand and manage these diseases.
This study uses detailed eye imaging to look for patterns that may go along with conditions like Alzheimer’s disease, memory problems, multiple sclerosis, or eye/vascular issues. It may help researchers better understand how eye findings relate to health and disease.
Hear when a new Hydroxychloroquine Retinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.